Ellis Robert J, Davies Christopher E, Keuskamp Dominic, Lazarus Benjamin, McDonald Stephen P
Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Kidney and Transplant Service, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Nephrology (Carlton). 2025 Mar;30(3):e70019. doi: 10.1111/nep.70019.
Evaluate the area-level incidence of kidney failure due to diabetes among Australians aged ≤ 45 years.
Using Australian registry and census data (2000-2022), incidence rates and prevalence of kidney failure (defined as commencing kidney replacement therapy) due to diabetes among people aged ≤ 45 years were compared by geographical region.
Incidence (per 100 000/year, 95% confidence interval) of kidney failure due to diabetes among people aged ≤ 45 years in Australia was 0.72 (0.68-0.77) in 2000-2011, and 1.13 (1.07-1.18) in 2012-2022 (incidence rate ratio [IRR] 1.56, 1.50-1.62). Between 2012 and 2022, there were 48 regions where the crude incidence of kidney failure due to diabetes was more than double the national average, the highest being 49.8 cases per 100 000 per year. Between 2012 and 2022, all jurisdictions had similar age-sex-adjusted point estimates for kidney failure incidence (range 0.78-1.48) except for the Northern Territory (15.8, 13.9-17.8). The most significant characteristics associated with the rate of incident kidney failure were residence in remote areas (IRR 13.9, 13.1-14.8, ref. major cities), socioeconomic disadvantage (IRR 2.96, 2.75-3.19, ref. advantaged areas), and Aboriginal and Torres Strait Islander ethnicity (IRR 24.2, 23.0-25.5). Between the eras, people born outside Australia had the largest increase in incident cases (IRR 2.47, 2.23-2.72) but had a lower overall incidence than those born in Australia (IRR 0.55, 0.52-0.59).
In Australia, there was an increase in the incidence of kidney failure due to diabetes among people aged ≤ 45 years in the last two decades. There was a strong relationship between the risk of kidney failure and social determinants of health, including place of residence, socioeconomic status and Indigenous status.
评估45岁及以下澳大利亚人因糖尿病导致肾衰竭的地区发病率。
利用澳大利亚登记处和人口普查数据(2000 - 2022年),按地理区域比较45岁及以下人群因糖尿病导致肾衰竭(定义为开始肾脏替代治疗)的发病率和患病率。
2000 - 2011年,澳大利亚45岁及以下人群因糖尿病导致肾衰竭的发病率(每10万人/年,95%置信区间)为0.72(0.68 - 0.77),2012 - 2022年为1.13(1.07 - 1.18)(发病率比[IRR] 1.56,1.50 - 1.62)。2012年至2022年期间,有48个地区因糖尿病导致肾衰竭的粗发病率超过全国平均水平的两倍,最高为每年每10万人49.8例。2012年至2022年期间,除北领地(15.8,13.9 - 17.8)外,所有司法管辖区因肾衰竭发病率的年龄 - 性别调整后的点估计值相似(范围为0.78 - 1.48)。与新发肾衰竭发生率最相关的显著特征是居住在偏远地区(IRR 13.9,13.1 - 14.8,参照大城市)、社会经济劣势(IRR 2.96,2.75 - 3.19,参照优势地区)以及原住民和托雷斯海峡岛民种族(IRR 24.2,23.0 - 25.5)。在不同时期之间,出生在澳大利亚境外的人新发病例增加最多(IRR 2.47,2.23 - 2.72),但总体发病率低于出生在澳大利亚的人(IRR 0.55,0.52 - 0.59)。
在澳大利亚,过去二十年中45岁及以下人群因糖尿病导致肾衰竭的发病率有所上升。肾衰竭风险与健康的社会决定因素之间存在密切关系,包括居住地、社会经济地位和原住民身份。